Eurofins Scientific reports strong Q1 growth and robust cash flow, reaffirming 2025/2027 targets. Explore ERFSF stock's path to higher margins and EPS gains.
Original Image Link
Source:seekingalpha.com
Original Image Link
Source:seekingalpha.com
Posted: 2025-05-15 07:30:00